In this SXSW panel, experts discuss the rapidly evolving landscape of alternative proteins, focusing on the technological and financial milestones needed to bring cultivated meat to the mainstream. Dr. Natalie Rubio, representing Arc Biotech and the Kaplan Lab, shares her insights on the transition from academic research to the private sector and the critical need for specialized bioreactors. The conversation highlights the collaborative spirit between startups, non-profits like the Good Food Institute, and government bodies to overcome hurdles such as high production costs and regulatory approvals.
The panelists remain optimistic about the potential for these technologies to address global challenges like food security and climate change. They emphasize that while billions in funding have already been secured, the next phase of growth will depend on scaling manufacturing and increasing consumer transparency. By fostering a diverse ecosystem of scientists, farmers, and entrepreneurs, the industry is working toward a future where sustainable, cell-based proteins become a standard choice for consumers worldwide.